The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial

Klein, K., McClure, E., Colaci, D., Thorsten, V., Hibberd, PL., Esamai, F., Garces, A., Patel, A., Saleem, S., Pasha, O., Chomba, E., Carlo, WA., Krebs, NF., Goudar, S., Derman, RJ., Liechty, EA., Koso-Thomas, M., Buekens, PM., Belizan, JM., ... Althabe, F. (2016). The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial. Reproductive Health, 13, e64. [64]. https://doi.org/10.1186/s12978-016-0179-z

Abstract

BACKGROUND: The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article

The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia